Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Penis | 22 | 2020 | 72 | 5.300 |
Why?
|
Piperazines | 6 | 2014 | 109 | 1.810 |
Why?
|
Myocytes, Smooth Muscle | 6 | 2020 | 84 | 1.540 |
Why?
|
Fibrosis | 15 | 2011 | 146 | 1.500 |
Why?
|
Oxidative Stress | 10 | 2020 | 874 | 1.450 |
Why?
|
Nitric Oxide Synthase | 11 | 2021 | 103 | 1.330 |
Why?
|
Nitric Oxide Synthase Type II | 9 | 2018 | 91 | 1.100 |
Why?
|
Nitric Oxide | 6 | 2023 | 287 | 1.060 |
Why?
|
Rats | 37 | 2021 | 3261 | 1.040 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2011 | 87 | 1.000 |
Why?
|
Sulfones | 5 | 2012 | 40 | 0.970 |
Why?
|
Aging | 12 | 2020 | 639 | 0.970 |
Why?
|
Cyclic GMP | 3 | 2019 | 44 | 0.880 |
Why?
|
Citrulline | 2 | 2019 | 7 | 0.840 |
Why?
|
Muscle, Smooth | 6 | 2019 | 51 | 0.780 |
Why?
|
Animals | 50 | 2022 | 14307 | 0.760 |
Why?
|
Apoptosis | 13 | 2020 | 1317 | 0.750 |
Why?
|
Arginine | 2 | 2019 | 62 | 0.740 |
Why?
|
Phosphodiesterase Inhibitors | 4 | 2007 | 30 | 0.710 |
Why?
|
Olacaceae | 1 | 2018 | 2 | 0.660 |
Why?
|
Paullinia | 1 | 2018 | 3 | 0.660 |
Why?
|
Transforming Growth Factor beta1 | 6 | 2011 | 91 | 0.650 |
Why?
|
Erectile Dysfunction | 5 | 2021 | 26 | 0.630 |
Why?
|
Neuroprotective Agents | 3 | 2012 | 231 | 0.600 |
Why?
|
Imidazoles | 2 | 2006 | 124 | 0.540 |
Why?
|
Male | 36 | 2022 | 18870 | 0.530 |
Why?
|
Ganglia | 1 | 2014 | 9 | 0.520 |
Why?
|
Rats, Inbred F344 | 12 | 2014 | 228 | 0.500 |
Why?
|
Rats, Sprague-Dawley | 10 | 2019 | 1534 | 0.490 |
Why?
|
Sulfonamides | 1 | 2014 | 75 | 0.490 |
Why?
|
Ganglia, Autonomic | 1 | 2012 | 3 | 0.440 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2012 | 4 | 0.440 |
Why?
|
Estrogens | 2 | 2006 | 190 | 0.440 |
Why?
|
Gene Expression | 5 | 2012 | 639 | 0.440 |
Why?
|
Penile Induration | 3 | 2008 | 19 | 0.420 |
Why?
|
Penile Erection | 5 | 2014 | 18 | 0.410 |
Why?
|
Impotence, Vasculogenic | 5 | 2009 | 11 | 0.400 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 2 | 2021 | 5 | 0.390 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2020 | 155 | 0.380 |
Why?
|
Vagina | 2 | 2009 | 81 | 0.370 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 89 | 0.370 |
Why?
|
Extracellular Matrix | 1 | 2011 | 111 | 0.370 |
Why?
|
Vascular Diseases | 2 | 2007 | 30 | 0.360 |
Why?
|
Purines | 4 | 2014 | 37 | 0.350 |
Why?
|
Peripheral Nerves | 1 | 2008 | 14 | 0.340 |
Why?
|
Cells, Cultured | 7 | 2019 | 1442 | 0.340 |
Why?
|
Transforming Growth Factor beta | 5 | 2008 | 183 | 0.340 |
Why?
|
Antioxidants | 1 | 2011 | 386 | 0.320 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2009 | 127 | 0.320 |
Why?
|
Immunohistochemistry | 9 | 2010 | 859 | 0.310 |
Why?
|
Calcitriol | 3 | 2012 | 30 | 0.300 |
Why?
|
Pituitary-Adrenal System | 2 | 2006 | 36 | 0.290 |
Why?
|
Muscle, Skeletal | 4 | 2011 | 257 | 0.290 |
Why?
|
Collagen | 4 | 2010 | 162 | 0.290 |
Why?
|
Obesity | 3 | 2022 | 965 | 0.290 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2006 | 49 | 0.280 |
Why?
|
Neurosecretory Systems | 1 | 2006 | 13 | 0.280 |
Why?
|
Adrenal Glands | 1 | 2006 | 17 | 0.280 |
Why?
|
Hypothalamus | 2 | 2020 | 122 | 0.260 |
Why?
|
Actins | 3 | 2010 | 142 | 0.240 |
Why?
|
Arteries | 2 | 2020 | 67 | 0.240 |
Why?
|
Nitric Oxide Synthase Type I | 7 | 2012 | 51 | 0.240 |
Why?
|
Mice | 13 | 2022 | 5668 | 0.240 |
Why?
|
Neural Crest | 1 | 2023 | 23 | 0.230 |
Why?
|
Nerve Tissue | 2 | 2014 | 7 | 0.230 |
Why?
|
Morphine | 2 | 2013 | 80 | 0.230 |
Why?
|
Hypoglycemic Agents | 3 | 2010 | 152 | 0.230 |
Why?
|
Spinal Cord | 1 | 2003 | 85 | 0.220 |
Why?
|
Interferon-gamma | 1 | 2023 | 235 | 0.220 |
Why?
|
Telencephalon | 1 | 2002 | 14 | 0.220 |
Why?
|
GAP-43 Protein | 1 | 2002 | 9 | 0.220 |
Why?
|
Choline O-Acetyltransferase | 1 | 2002 | 32 | 0.220 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 131 | 0.210 |
Why?
|
Nucleotides, Cyclic | 1 | 2021 | 6 | 0.210 |
Why?
|
Appetite | 2 | 2020 | 19 | 0.210 |
Why?
|
Muscle Development | 2 | 2012 | 44 | 0.210 |
Why?
|
Nerve Degeneration | 1 | 2002 | 101 | 0.210 |
Why?
|
Blotting, Western | 10 | 2009 | 834 | 0.210 |
Why?
|
Neurons | 6 | 2020 | 1130 | 0.200 |
Why?
|
Neurogenesis | 3 | 2020 | 55 | 0.200 |
Why?
|
Drosophila Proteins | 1 | 2003 | 162 | 0.200 |
Why?
|
Adipose Tissue | 1 | 2022 | 167 | 0.200 |
Why?
|
Carrier Proteins | 1 | 2003 | 287 | 0.200 |
Why?
|
Hyperphagia | 1 | 2020 | 14 | 0.190 |
Why?
|
Cell Differentiation | 5 | 2020 | 562 | 0.190 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 23 | 0.190 |
Why?
|
Disease Models, Animal | 4 | 2014 | 1300 | 0.180 |
Why?
|
Animal Feed | 1 | 2020 | 42 | 0.180 |
Why?
|
In Situ Nick-End Labeling | 2 | 2010 | 126 | 0.180 |
Why?
|
Animals, Newborn | 1 | 2020 | 323 | 0.180 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2019 | 34 | 0.180 |
Why?
|
Nitrites | 1 | 2019 | 38 | 0.180 |
Why?
|
Enzyme Inhibitors | 4 | 2011 | 396 | 0.170 |
Why?
|
Stem Cell Transplantation | 2 | 2009 | 31 | 0.170 |
Why?
|
Multipotent Stem Cells | 3 | 2023 | 16 | 0.160 |
Why?
|
Mice, Knockout | 2 | 2011 | 897 | 0.160 |
Why?
|
Thiazolidinediones | 2 | 2009 | 48 | 0.160 |
Why?
|
Hippocampus | 3 | 2008 | 546 | 0.160 |
Why?
|
Myostatin | 4 | 2011 | 57 | 0.160 |
Why?
|
RNA, Messenger | 6 | 2013 | 1152 | 0.150 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 50 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2009 | 592 | 0.150 |
Why?
|
RNA, Small Interfering | 3 | 2008 | 391 | 0.140 |
Why?
|
Cell Proliferation | 3 | 2011 | 1149 | 0.140 |
Why?
|
Triazines | 2 | 2006 | 19 | 0.140 |
Why?
|
Proprotein Convertase 1 | 2 | 2013 | 11 | 0.140 |
Why?
|
Proprotein Convertase 2 | 2 | 2013 | 16 | 0.140 |
Why?
|
Signal Transduction | 5 | 2012 | 1802 | 0.130 |
Why?
|
Reactive Oxygen Species | 3 | 2007 | 416 | 0.130 |
Why?
|
Heme Oxygenase-1 | 1 | 2014 | 46 | 0.130 |
Why?
|
Cholecalciferol | 1 | 2014 | 19 | 0.130 |
Why?
|
Cholinergic Fibers | 2 | 2006 | 8 | 0.130 |
Why?
|
Group II Phospholipases A2 | 1 | 2014 | 3 | 0.120 |
Why?
|
Brain | 2 | 2013 | 1268 | 0.120 |
Why?
|
Up-Regulation | 2 | 2014 | 490 | 0.120 |
Why?
|
Nerve Growth Factor | 1 | 2014 | 25 | 0.120 |
Why?
|
Neurites | 1 | 2014 | 35 | 0.120 |
Why?
|
Pro-Opiomelanocortin | 1 | 2013 | 14 | 0.120 |
Why?
|
Morphine Dependence | 1 | 2013 | 25 | 0.120 |
Why?
|
Narcotics | 1 | 2013 | 28 | 0.120 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 968 | 0.110 |
Why?
|
Pregnancy | 4 | 2022 | 1503 | 0.110 |
Why?
|
Neurturin | 1 | 2012 | 2 | 0.110 |
Why?
|
Pelvis | 1 | 2012 | 14 | 0.110 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 165 | 0.110 |
Why?
|
Fibroblasts | 3 | 2009 | 252 | 0.110 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2012 | 60 | 0.110 |
Why?
|
Eating | 1 | 2013 | 152 | 0.110 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 70 | 0.110 |
Why?
|
Molsidomine | 1 | 2011 | 4 | 0.100 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 176 | 0.100 |
Why?
|
Nitric Oxide Donors | 1 | 2011 | 18 | 0.100 |
Why?
|
Allopurinol | 1 | 2011 | 11 | 0.100 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2011 | 8 | 0.100 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2011 | 14 | 0.100 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2011 | 22 | 0.100 |
Why?
|
Epidermal Growth Factor | 1 | 2011 | 63 | 0.100 |
Why?
|
Xanthine Dehydrogenase | 1 | 2010 | 2 | 0.100 |
Why?
|
Aorta | 2 | 2009 | 161 | 0.100 |
Why?
|
Cytokines | 1 | 2014 | 569 | 0.100 |
Why?
|
Phospholipases A2 | 1 | 2010 | 8 | 0.090 |
Why?
|
Stem Cells | 2 | 2008 | 132 | 0.090 |
Why?
|
Denervation | 2 | 2007 | 26 | 0.090 |
Why?
|
Rats, Inbred BN | 3 | 2005 | 19 | 0.090 |
Why?
|
Cell Shape | 1 | 2010 | 35 | 0.090 |
Why?
|
Isoenzymes | 1 | 2010 | 149 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 1 | 2010 | 54 | 0.090 |
Why?
|
Tissue Scaffolds | 1 | 2009 | 24 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2013 | 418 | 0.090 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2009 | 6 | 0.090 |
Why?
|
Tunica Media | 1 | 2009 | 14 | 0.090 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 229 | 0.090 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2008 | 42 | 0.090 |
Why?
|
Kidney Tubules | 1 | 2009 | 28 | 0.090 |
Why?
|
Endothelium | 1 | 2008 | 31 | 0.090 |
Why?
|
Caspase 2 | 1 | 2008 | 6 | 0.080 |
Why?
|
Insulin | 1 | 2010 | 224 | 0.080 |
Why?
|
Random Allocation | 1 | 2008 | 139 | 0.080 |
Why?
|
Cell Cycle | 1 | 2010 | 309 | 0.080 |
Why?
|
Myoblasts | 1 | 2008 | 25 | 0.080 |
Why?
|
Group V Phospholipases A2 | 1 | 2007 | 1 | 0.080 |
Why?
|
Mesoderm | 1 | 2008 | 70 | 0.080 |
Why?
|
Carbolines | 1 | 2007 | 13 | 0.080 |
Why?
|
Fetal Nutrition Disorders | 1 | 2007 | 9 | 0.080 |
Why?
|
Prostatectomy | 1 | 2007 | 56 | 0.080 |
Why?
|
PPAR gamma | 1 | 2007 | 49 | 0.080 |
Why?
|
Humans | 10 | 2023 | 34853 | 0.070 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2006 | 5 | 0.070 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 2006 | 11 | 0.070 |
Why?
|
Proprotein Convertases | 1 | 2006 | 8 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2006 | 22 | 0.070 |
Why?
|
Malnutrition | 1 | 2007 | 45 | 0.070 |
Why?
|
Hypothyroidism | 1 | 2006 | 18 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2006 | 20 | 0.070 |
Why?
|
Gene Transfer Techniques | 1 | 2006 | 43 | 0.070 |
Why?
|
Protein Precursors | 1 | 2006 | 59 | 0.070 |
Why?
|
Estradiol | 1 | 2008 | 244 | 0.070 |
Why?
|
Rats, Wistar | 1 | 2006 | 202 | 0.070 |
Why?
|
Prosencephalon | 1 | 2006 | 25 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2006 | 28 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 149 | 0.070 |
Why?
|
Steroids | 1 | 2006 | 43 | 0.070 |
Why?
|
Cerebral Cortex | 1 | 2007 | 274 | 0.070 |
Why?
|
Female | 6 | 2022 | 19873 | 0.070 |
Why?
|
Administration, Oral | 1 | 2006 | 212 | 0.070 |
Why?
|
Germ Cells | 1 | 2005 | 70 | 0.060 |
Why?
|
Models, Animal | 2 | 2021 | 131 | 0.060 |
Why?
|
Plasminogen Inactivators | 1 | 2004 | 3 | 0.060 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2004 | 14 | 0.060 |
Why?
|
Rats, Zucker | 3 | 2009 | 22 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2005 | 338 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2004 | 45 | 0.060 |
Why?
|
Arteriosclerosis | 1 | 2004 | 35 | 0.060 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2003 | 19 | 0.060 |
Why?
|
SOX Transcription Factors | 1 | 2023 | 3 | 0.060 |
Why?
|
Mouth Mucosa | 1 | 2023 | 33 | 0.060 |
Why?
|
Narcotic Antagonists | 2 | 2013 | 50 | 0.060 |
Why?
|
Dyneins | 1 | 2003 | 6 | 0.060 |
Why?
|
Phosphorylation | 3 | 2013 | 878 | 0.060 |
Why?
|
Enzyme Activation | 1 | 2004 | 423 | 0.060 |
Why?
|
Weaning | 1 | 2022 | 15 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2003 | 134 | 0.060 |
Why?
|
Septal Nuclei | 1 | 2002 | 3 | 0.060 |
Why?
|
Receptors, Calcitriol | 2 | 2014 | 59 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 184 | 0.050 |
Why?
|
Virus Replication | 1 | 2023 | 261 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2013 | 1530 | 0.050 |
Why?
|
Neural Pathways | 1 | 2002 | 120 | 0.050 |
Why?
|
Reproduction | 1 | 2002 | 63 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2021 | 90 | 0.050 |
Why?
|
Cell Line | 3 | 2012 | 1289 | 0.050 |
Why?
|
Adiposity | 1 | 2022 | 145 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2021 | 91 | 0.050 |
Why?
|
Satiation | 1 | 2020 | 8 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 115 | 0.050 |
Why?
|
Agouti-Related Protein | 1 | 2020 | 11 | 0.050 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 49 | 0.050 |
Why?
|
Diet | 2 | 2022 | 747 | 0.050 |
Why?
|
Mitochondria | 1 | 2004 | 454 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 79 | 0.050 |
Why?
|
Electroporation | 3 | 2006 | 18 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2014 | 351 | 0.040 |
Why?
|
Genetic Vectors | 3 | 2006 | 154 | 0.040 |
Why?
|
Body Weight | 2 | 2013 | 404 | 0.040 |
Why?
|
Computational Biology | 1 | 2021 | 275 | 0.040 |
Why?
|
Protein Transport | 2 | 2014 | 286 | 0.040 |
Why?
|
Plasmids | 3 | 2006 | 233 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2010 | 197 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2018 | 42 | 0.040 |
Why?
|
Phenols | 1 | 2018 | 76 | 0.040 |
Why?
|
Time Factors | 2 | 2013 | 1681 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 152 | 0.030 |
Why?
|
PC12 Cells | 1 | 2014 | 84 | 0.030 |
Why?
|
Drug Implants | 1 | 2013 | 19 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 34 | 0.030 |
Why?
|
Pain Threshold | 1 | 2013 | 24 | 0.030 |
Why?
|
Naltrexone | 1 | 2013 | 30 | 0.030 |
Why?
|
Pituitary Gland | 1 | 2013 | 59 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 145 | 0.030 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2012 | 4 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2012 | 9 | 0.030 |
Why?
|
beta-Galactosidase | 2 | 2002 | 34 | 0.030 |
Why?
|
Adenoviridae | 2 | 2002 | 59 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2012 | 41 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2013 | 103 | 0.030 |
Why?
|
Testis | 2 | 2005 | 185 | 0.030 |
Why?
|
Electric Stimulation | 2 | 2002 | 177 | 0.030 |
Why?
|
DNA, Complementary | 2 | 2002 | 175 | 0.030 |
Why?
|
MyoD Protein | 1 | 2011 | 9 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 157 | 0.030 |
Why?
|
Growth Differentiation Factors | 1 | 2011 | 7 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2011 | 22 | 0.030 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2011 | 22 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2011 | 54 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2012 | 283 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 984 | 0.020 |
Why?
|
Genes, cdc | 1 | 2010 | 8 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 161 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2010 | 30 | 0.020 |
Why?
|
Biological Assay | 1 | 2010 | 56 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2010 | 29 | 0.020 |
Why?
|
Uterine Prolapse | 1 | 2009 | 3 | 0.020 |
Why?
|
Muscle Cells | 1 | 2009 | 12 | 0.020 |
Why?
|
Intestine, Small | 1 | 2009 | 24 | 0.020 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2010 | 42 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 87 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2009 | 30 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 298 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2010 | 119 | 0.020 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2009 | 115 | 0.020 |
Why?
|
Caspase 9 | 1 | 2008 | 27 | 0.020 |
Why?
|
Mineralocorticoids | 1 | 2008 | 1 | 0.020 |
Why?
|
Adrenal Cortex | 1 | 2008 | 3 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 2008 | 132 | 0.020 |
Why?
|
Smad Proteins | 1 | 2008 | 12 | 0.020 |
Why?
|
Aldehydes | 1 | 2008 | 65 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 73 | 0.020 |
Why?
|
Indolizines | 1 | 2007 | 4 | 0.020 |
Why?
|
Carbamates | 1 | 2007 | 11 | 0.020 |
Why?
|
Follistatin | 1 | 2008 | 27 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2008 | 80 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 139 | 0.020 |
Why?
|
Arterioles | 1 | 2007 | 18 | 0.020 |
Why?
|
Mesenteric Arteries | 1 | 2007 | 18 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 210 | 0.020 |
Why?
|
Lac Operon | 1 | 2006 | 19 | 0.020 |
Why?
|
Neuroglia | 1 | 2007 | 117 | 0.020 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 2006 | 25 | 0.020 |
Why?
|
Kidney | 1 | 2009 | 322 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2008 | 485 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2006 | 132 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 600 | 0.020 |
Why?
|
Down-Regulation | 1 | 2008 | 420 | 0.020 |
Why?
|
Gene Silencing | 1 | 2006 | 143 | 0.020 |
Why?
|
Transfection | 1 | 2006 | 496 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 650 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 162 | 0.020 |
Why?
|
Blood Pressure | 1 | 2009 | 613 | 0.020 |
Why?
|
Base Sequence | 1 | 2006 | 932 | 0.020 |
Why?
|
Inflammation | 1 | 2009 | 577 | 0.020 |
Why?
|
Cytochromes c | 1 | 2004 | 45 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 1007 | 0.020 |
Why?
|
Pentoxifylline | 1 | 2003 | 6 | 0.020 |
Why?
|
Caspases | 1 | 2004 | 132 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2004 | 116 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2004 | 213 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 101 | 0.010 |
Why?
|
Caspase 3 | 1 | 2004 | 194 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 642 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 465 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 605 | 0.010 |
Why?
|
Hypertension | 1 | 2008 | 770 | 0.010 |
Why?
|
Aged | 1 | 2008 | 6448 | 0.010 |
Why?
|
Middle Aged | 1 | 2008 | 9642 | 0.010 |
Why?
|